New Wave Ventures

Xerion Healthcare develop nanoparticles that are used to improve treatment of cancer. The nanoparticles are injected into tumours just prior to standard radiotherapy and act to enhance the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays. The nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. Xerion Healthcare are currently developing the treatment for head and neck and pancreatic tumours.

The ID Co., builds products based on (open) bank data that help businesses onboard their customers quickly. DirectID, their business service, helps businesses like lenders to create exceptional customer experiences by removing friction caused during the application process by the current challenges of risk, compliance, fraud, and regulation. The products They provide solve business pains such as assessing customers' affordability and verifying their account information, thereby offsetting credit risk. The platform currently connects to 5,500 banks in 30 countries and will soon support Open Banking in the UK. They presently have more than 30 customers on the platform and have just launched with Clydesdale, a leading UK retail bank, to provide bank data as part of their mobile app experience. The business is authorised by the FCA to provide AISP (Account Information Service Provider) services to the UK market.

Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.

Regenerys Ltd. develops and sells regenerative medicine products in the streams requiring bioprocessing and biostorage. The company offers Myskin, a product for the autologous treatment of serious burns and difficult to heal wounds using cultured allegoneic cells from the patient’s own skin; and Cryoskin, a medicine for the treatment of burns using autologous cells. It also provides Adiposet, a service to facilitate better cosmetic outcomes in breast cancer surgery and other cosmetic procedures by enabling the storage and return of adipose tissue for lipomodellin. In addition, the company offers third party bio-processing and bio-storage services through its laboratories. It serves NHS and private healthcare providers in the United Kingdom and other parts of Europe. The company was incorporated in 2011 and is based in Cambridge, United Kingdom.

Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.

Aeristech Limited develops electric air compressors for the automotive industry in the United Kingdom and internationally. Its products include electric superchargers that deliver air pressure and flow continuously without adding complexity or exotic materials to the motor or compressor; full electric turbochargers for engine downsizing and efficiency; and fuel cell air compressors that deliver air pressure regardless of changes in air flow or variation in input voltage. The company was founded in 2006 and is based in Kenilworth, United Kingdom.

The ID Co., builds products based on (open) bank data that help businesses onboard their customers quickly. DirectID, their business service, helps businesses like lenders to create exceptional customer experiences by removing friction caused during the application process by the current challenges of risk, compliance, fraud, and regulation. The products They provide solve business pains such as assessing customers' affordability and verifying their account information, thereby offsetting credit risk. The platform currently connects to 5,500 banks in 30 countries and will soon support Open Banking in the UK. They presently have more than 30 customers on the platform and have just launched with Clydesdale, a leading UK retail bank, to provide bank data as part of their mobile app experience. The business is authorised by the FCA to provide AISP (Account Information Service Provider) services to the UK market.

The ID Co., builds products based on (open) bank data that help businesses onboard their customers quickly. DirectID, their business service, helps businesses like lenders to create exceptional customer experiences by removing friction caused during the application process by the current challenges of risk, compliance, fraud, and regulation. The products They provide solve business pains such as assessing customers' affordability and verifying their account information, thereby offsetting credit risk. The platform currently connects to 5,500 banks in 30 countries and will soon support Open Banking in the UK. They presently have more than 30 customers on the platform and have just launched with Clydesdale, a leading UK retail bank, to provide bank data as part of their mobile app experience. The business is authorised by the FCA to provide AISP (Account Information Service Provider) services to the UK market.

Surface Generation is a privately-owned high technology and manufacturing company headquartered in the UK and with facilities in North America and Asia. Its patented Production to Functional Specification (PtFS) technology enables manufacturers in the aerospace, automotive and consumer electronics sectors to work with composite materials, saving costs, energy and producing significantly lighter weight products.

Endomag is a medical technology company devoted to improving the global standard of cancer care. The company's Sentimag probe, Magseed marker, and Magtrac node marker are already in use by many of the world’s leading physicians and cancer centers. Endomag's goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. As of 2019, the company has already helped 70,000+ women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), Endomag continues to develop its unique clinical platform from its headquarters in Cambridge, United Kingdom. The company sells its products through a network of distributors in Europe, the Middle East, Africa, and Australasia.

The ID Co., builds products based on (open) bank data that help businesses onboard their customers quickly. DirectID, their business service, helps businesses like lenders to create exceptional customer experiences by removing friction caused during the application process by the current challenges of risk, compliance, fraud, and regulation. The products They provide solve business pains such as assessing customers' affordability and verifying their account information, thereby offsetting credit risk. The platform currently connects to 5,500 banks in 30 countries and will soon support Open Banking in the UK. They presently have more than 30 customers on the platform and have just launched with Clydesdale, a leading UK retail bank, to provide bank data as part of their mobile app experience. The business is authorised by the FCA to provide AISP (Account Information Service Provider) services to the UK market.

SPARKL designs and develops the SPARKL Sequencing Engine, which lets you manage the behaviour of all your distributed machines, systems and applications. It uses our simple, declarative Clear Box configuration to make them work together intelligently, generating a tamper-proof audit trail for regulatory compliance and system performance. SPARKL is based in London and works with partners including Cisco and Intel to market the product to users and customers worldwide.

Spectromics develops a diagnostic system that helps to guide antibiotic treatment. It provides a point-of-prescription test for bacterial infections that guides the treatment of antibiotics. Spectromics began operation in 2014. Its headquarters is in Manchester in the United Kingdom.

Enhanced Telecommunications Ltd, dba Netmania Solutions, specialist device management practitioners with experience of standards based solutions, has been involved in TR-069 delivery and deployments since 2001, enabling operators to improve the customer journey, reduce churn and improve profitability.

Orthogem develops and manufactures synthetic bone grafts. Its patented Tripore technology platform has enabled the creation of a pipeline of SBG's formulated for a variety of clinical applications, ranging from spinal to oral cranial facial surgery. Orthogem's products include TriPore Granules, TriPore MPA, and TriPore Blocks. Wei Lo founded it in 2001, with its headquarters in Nottingham in the United Kingdom.

Tapit Media Pty Ltd. develops a contactless management platform for outdoor, retail, and government markets. Its platform provides a range of contactless technologies, including Near Field Communications and Beacons that allow clients to create, deliver, manage, and report in real-time across a range of their physical based Tapit enabled infrastructure. The company was founded in 2011 and is based in Sydney, Australia with additional offices in New York, New York; and Toronto, Canada.

Nanna Therapeutics is a drug discovery company addressing age-related diseases for which others are failing to provide effective treatments. These include mitochondrial, neurodegenerative, cardiovascular or metabolic, joint or tissue disease as well as cancer. Nanna Therapeutics are targeting fundamental cellular processes to create drugs to treat age-related diseases and improve longevity. Such drugs include those to combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. With a strong focus on mitochondria, the energy source in every cell, we can target the fundamental causes of many age-related diseases. Through this approach we can also address debilitating, life-limiting mitochondrial diseases for which there are currently few effective therapies. Nanna Therapeutics has developed a tightly integrated set of proprietary technologies that radically disrupt current methods of creating new medicines. This Totally Integrated Medicines Engine (TIME) has been devised to answer the needs of drug discovery and development scientists utilising the best in 21st century technologies of microfluidics, nanofabrication and artificial intelligence.

The ID Co., builds products based on (open) bank data that help businesses onboard their customers quickly. DirectID, their business service, helps businesses like lenders to create exceptional customer experiences by removing friction caused during the application process by the current challenges of risk, compliance, fraud, and regulation. The products They provide solve business pains such as assessing customers' affordability and verifying their account information, thereby offsetting credit risk. The platform currently connects to 5,500 banks in 30 countries and will soon support Open Banking in the UK. They presently have more than 30 customers on the platform and have just launched with Clydesdale, a leading UK retail bank, to provide bank data as part of their mobile app experience. The business is authorised by the FCA to provide AISP (Account Information Service Provider) services to the UK market.

Surrey NanoSystems manufactures nanoscale materials for use in engineering and product applications. It offers Vantablack, a super-black coating that is applied to surfaces using vacuum-deposition technology, as well as for spraying and post-processing. Surrey NanoSystem’s Vantablack is used in various applications, such as stray light suppression, architectural lighting, aesthetic applications, calibration sources, sensors, telescopes, architecture, IR imaging systems, spectroscopy, automotive, cinematography optics, satellite calibration sources, camera lenses, and other applications. CEVP that began operation in 2006 became Surrey NanoSystems in December 2006, with its headquarters in Newhaven in the United Kingdom.